Description

Meropenam, developed together by Sumitomo Pharmaceuticals Co., Ltd and Imperial Chemical Industries Ltd, belongs to the second generation of broad-spectrum carbapenem and the first carbapenem which can be used alone. In 2014, the sales value of meropenam in the global market reached top to USD 1413 million with year-on-year growth of 2.91%.

Meropenam is the carbapenem with the largest number of manufacturers and highest annual output in today’s China. According to the statistics, there are about 25 manufacturers of meropenam (chemical enterprises included) in China. The division of labor is clear-cut, for example, some are responsible for mother nucleus, some for branched chain intermediate and others for Active Pharmaceutical Ingredient (API) synthesis. Major manufacturers of meropenam preparations in China are as follows: Shenzhen Haibin Pharmaceutical Co., Ltd, Hisun-Pfizer Pharmaceuticals Co., Ltd, Haikou Pharmaceutical Factory Co., Ltd, Shijiazhuang Pharma. Group Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. The sales value of meropenam in Chinese market reached CNY 968 million in 2014 and the CAGR during the period of 2005-2014 reached top to 27.1%.

View Full Report at: http://www.marketresearchreports.biz/analysis/289064


It is widely believed in the medical field that meropenam is one of the few broad-spectrum antibiotics that can treat various infectious diseases. Therefore, meropenam will remain the main antibiotic for clinical medicine around the world and its sales in China is expected to keep increasing in the next few years.

Readers can get at least the following information through this report:

market size of meropenam in China
major manufacturers of meropenam in the Chinese market and their market share
retail price of meropenam in Chinese market
market outlook of meropenam in China

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/289064




The author suggests the following groups of people purchase this report:

manufacturers of antibiotics
investors/ research institutions interested in Chinese medicine market
any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Content

1 Related Concepts of Meropenam
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Meropenam in China
2.1 Patent Status
2.2 Major Manufacturers

3 Survey on Sales Status of Meropenam in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Meropenam in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Meropenam in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume


Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz


Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz


Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]